» Articles » PMID: 34402717

Resveratrol Supplementation Reduces ACE2 Expression in Human Adipose Tissue

Overview
Journal Adipocyte
Date 2021 Aug 17
PMID 34402717
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin converting enzyme-2 (ACE2) is the cell-surface receptor enabling cellular entry of SARS-CoV-2. ACE2 is highly expressed in adipose tissue (AT), rendering AT a potential SARS-CoV-2 reservoir contributing to massive viral spread in COVID-19 patients with obesity. Although rodent and cell studies suggest that the polyphenol resveratrol alters ACE2, human studies are lacking. Here, we investigated the effects of 30-days resveratrol supplementation on RAS components in AT and skeletal muscle in men with obesity in a placebo-controlled cross-over study. Resveratrol markedly decreased ACE2 (~40%) and leptin (~30%), but did neither alter angiotensinogen, ACE and AT1R expression in AT nor skeletal muscle RAS components. These findings demonstrate that resveratrol supplementation reduces ACE2 in AT, which might dampen SARS-CoV-2 spread in COVID-19.

Citing Articles

Comparative analysis of COVID-19 responses in Japan and Africa: diet, phytochemicals, vitamin D, and gut microbiota in reducing mortality-A systematic review and meta-analysis.

Santa K, Tamaki R, Watanabe K, Nagaoka I Front Nutr. 2024; 11:1465324.

PMID: 39434894 PMC: 11492870. DOI: 10.3389/fnut.2024.1465324.


Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy.

Vajdi M, Karimi A, Hassanizadeh S, Farhangi M, Bagherniya M, Askari G Pharmacol Rep. 2024; 76(2):307-327.

PMID: 38498260 DOI: 10.1007/s43440-024-00585-6.


Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms' Severity.

Pavlidou E, Poulios E, Papadopoulou S, Fasoulas A, Dakanalis A, Giaginis C Med Sci (Basel). 2024; 12(1).

PMID: 38390861 PMC: 10885051. DOI: 10.3390/medsci12010011.


Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities.

Brown K, Theofanous D, Britton R, Aburido G, Pepper C, Sri Undru S Int J Mol Sci. 2024; 25(2).

PMID: 38255828 PMC: 10815776. DOI: 10.3390/ijms25020747.


Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph-Based Approach.

Lou P, Fang A, Zhao W, Yao K, Yang Y, Hu J J Med Internet Res. 2023; 25:e45225.

PMID: 37862061 PMC: 10592722. DOI: 10.2196/45225.


References
1.
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J, Turner A . Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126(10):1456-1474. PMC: 7188049. DOI: 10.1161/CIRCRESAHA.120.317015. View

2.
Ryan P, Caplice N . Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?. Obesity (Silver Spring). 2020; 28(7):1191-1194. PMC: 7264526. DOI: 10.1002/oby.22843. View

3.
Tiao M, Lin Y, Yu H, Sheen J, Lin I, Lai Y . Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. Lipids Health Dis. 2018; 17(1):178. PMC: 6064630. DOI: 10.1186/s12944-018-0824-3. View

4.
Konings E, Timmers S, Boekschoten M, Goossens G, Jocken J, Afman L . The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. Int J Obes (Lond). 2013; 38(3):470-3. DOI: 10.1038/ijo.2013.155. View

5.
Goossens G, Blaak E, van Baak M . Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev. 2003; 4(1):43-55. DOI: 10.1046/j.1467-789x.2003.00091.x. View